What is the 13F Pro Quality Score for SGRY?

13F Pro ranks Surgery Partners, Inc. (SGRY) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View SGRY's current score at https://13fpro.ai/company/SGRY (free sign-up required for the full ranking).

Where does 13F Pro source SGRY data?

All Surgery Partners, Inc. fundamentals and ownership data come directly from SEC EDGAR. Surgery Partners, Inc. files with the SEC under CIK 1638833. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is SGRY in?

Surgery Partners, Inc. (SGRY) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is SGRY research updated on 13F Pro?

SGRY's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Surgery Partners, Inc.(SGRY)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1638833 SGRY stock profile & AI dashboard →

13F Pro Quality Score

53.1/100

Rank #1,411 of 2,961 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

57.3/100

Profitability

34.1/100

Balance Sheet

30.2/100

Earnings Quality

85.8/100

Free Cash Flow

44.1/100

Institutional Flow

28.3/100

Revenue Scale

71.8/100

Dilution Risk

76.9/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why SGRY Scores 53/100

exact factor attribution · 2026-09-11

SGRY's composite is driven by earnings quality and scale, held back by profitability and capital efficiency. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings quality

+3.6 pts

86th pct

Scale

+3.3 pts

72th pct

Revenue growth

+1.5 pts

57th pct

Shareholder dilution

+1.4 pts

77th pct

Earnings growth

-0.2 pts

46th pct

Free cash flow

-0.9 pts

44th pct

Institutional flow

-1.1 pts

28th pct

Capital efficiency

-2.0 pts

30th pct

Profitability

-2.4 pts

34th pct

Latest change (2026-08-10): 48 → 46 · ↓ Revenue growth 63→47

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

SGRY Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Surgery Partners, Inc. (SGRY), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SGRY at 53.1/100 on a 32-signal composite quality model, placing it at rank #1,411 of 2,961 stocks — the top half of the AI-ranked universe. SGRY scores in the top quartile across earnings quality (85.8). Areas of concern include institutional flow (28.3) and balance sheet strength (30.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Surgery Partners, Inc. reports quarterly revenue of $848.9M, net income of $-15.0M, an operating margin of 12.0%. Top institutional holders of SGRY by reported 13-F value include BAIN CAPITAL INVESTORS, Jupiter Topco, Pentwater Capital Management, based on the most recent SEC filings. SGRY trades on the Nasdaq exchange and files with the SEC under CIK 1638833. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SGRY daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Surgery Partners, Inc. directly from SEC EDGAR. Surgery Partners, Inc.'s 13F Pro composite quality score has ranged between 46 and 57 since 2026, currently 53.1 — an improving long-term trajectory across 48 quarterly and live scoring snapshots.

✦

Fun facts about Surgery Partners, Inc.

Quirks, history, and lore behind SGRY — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare services company · listed on Nasdaq · headquartered in Tennessee · operates in the outpatient segment of the medical industry.
2
The Numbers
Generates roughly $2–3 billion in annual revenue and operates or manages hundreds of surgical facilities across more than 30 states — a footprint that keeps expanding.
3
The History
Built largely through acquisitions, the company has grown by snapping up independent surgical facilities and folding them into a national network since its early days in the 2010s.
4
The Secret
Its business model bets on the decade-long shift of complex procedures out of expensive hospitals and into lower-cost, physician-friendly ambulatory settings — a trend regulators and insurers actively encourage.
5
The Lore
Private equity giant H.I.G. Capital helped assemble the company before its public debut, and major investor Bain Capital has held a significant stake — giving this mid-cap a very blue-chip back story.
6
The Giveaway
Its name literally tells you what it does and where it does it: surgical procedures, handled by a network of ambulatory surgery centers, run by a company whose ticker is SGRY.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$848.9M

Net Income

Q2 2026

$-15.0M

Free Cash Flow

Q2 2026

$37.5M

Operating Margin

Q2 2026

12.0%

ROIC

Q2 2026

7.5%

D/E Ratio

Q2 2026

2.25

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+6.2% YoY

$3.31BFY 2025

FY22 $2.54BFY23 $2.74BFY24 $3.11BFY25 $3.31B

Net Income

+53.7% YoY

$-77.9MFY 2025

FY22 $-54.6MFY23 $-11.9MFY24 $-168.1MFY25 $-77.9M

Operating Income

+11.7% YoY

$389.5MFY 2025

FY22 $345.2MFY23 $328.0MFY24 $348.8MFY25 $389.5M

EPS (Diluted)

+54.1% YoY

$-0.61FY 2025

FY22 $-0.59FY23 $-0.09FY24 $-1.33FY25 $-0.61

Total Assets

+2.9% YoY

$8.12BFY 2025

FY22 $6.68BFY23 $6.88BFY24 $7.89BFY25 $8.12B

Total Debt

+9.4% YoY

$3.83BFY 2025

FY22 $2.70BFY23 $2.88BFY24 $3.51BFY25 $3.83B

Op. Cash Flow

-8.6% YoY

$274.3MFY 2025

FY22 $158.8MFY23 $293.8MFY24 $300.1MFY25 $274.3M

Free Cash Flow

-6.7% YoY

$195.6MFY 2025

FY22 $78.2MFY23 $205.0MFY24 $209.7MFY25 $195.6M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$3.31B +6.2%	$3.11B +13.5%	$2.74B +8.0%	$2.54B +14.1%	$2.23B +19.6%	$1.86B
Net Income	$-77.9M +53.7%	$-168.1M -1312.6%	$-11.9M +78.2%	$-54.6M +23.0%	$-70.9M +38.9%	$-116.1M
Operating Income	$389.5M +11.7%	$348.8M +6.3%	$328.0M -5.0%	$345.2M +14.2%	$302.2M +65.1%	$183.0M
EPS (Diluted)	$-0.61 +54.1%	$-1.33 -1377.8%	$-0.09 +84.7%	$-0.59 +47.3%	$-1.12 +64.9%	$-3.19
Total Assets	$8.12B +2.9%	$7.89B +14.7%	$6.88B +2.9%	$6.68B +9.2%	$6.12B +13.0%	$5.41B
Total Debt	$3.83B +9.4%	$3.51B +21.9%	$2.88B +6.7%	$2.70B -10.7%	$3.02B +2.6%	$2.94B
Operating Cash Flow	$274.3M -8.6%	$300.1M +2.1%	$293.8M +85.0%	$158.8M +82.3%	$87.1M -64.7%	$246.9M
Free Cash Flow	$195.6M -6.7%	$209.7M +2.3%	$205.0M +162.1%	$78.2M +165.1%	$29.5M -85.5%	$204.0M

Get alerted when SGRY's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Surgery Partners, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of SGRY

BAIN CAPITAL INVESTORS LLC
$839.1M49,946,972 sh
Jupiter Topco LLC
$233.2M13,882,155 sh
Pentwater Capital Management LP
$195.4M11,630,000 sh
UBS Group AG
$144.0M8,573,413 sh
BlackRock, Inc.
$104.9M6,241,503 sh
KING STREET CAPITAL MANAGEMENT, L.P.
$101.8M6,058,141 sh
T. Rowe Price Investment Management, Inc.
$99.4M5,916,197 sh
DIMENSIONAL FUND ADVISORS LP
$83.1M4,943,713 sh
Clearbridge Investments, LLC
$64.2M3,823,179 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$62.8M3,737,712 sh

Fund	Value	Shares
BAIN CAPITAL INVESTORS LLC	$839.1M	49,946,972
Jupiter Topco LLC	$233.2M	13,882,155
Pentwater Capital Management LP	$195.4M	11,630,000
UBS Group AG	$144.0M	8,573,413
BlackRock, Inc.	$104.9M	6,241,503
KING STREET CAPITAL MANAGEMENT, L.P.	$101.8M	6,058,141
T. Rowe Price Investment Management, Inc.	$99.4M	5,916,197
DIMENSIONAL FUND ADVISORS LP	$83.1M	4,943,713
Clearbridge Investments, LLC	$64.2M	3,823,179
VANGUARD PORTFOLIO MANAGEMENT LLC	$62.8M	3,737,712

Companies Similar to SGRY

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

AHCO

AdaptHealth Corp.

AI score

Similar quality profile · 3 shared holders

KENNEDY CAPITAL MANAGEMENT LLC DIMENSION CAPITAL MANAGEMENT LLC ARISTEIA CAPITAL, L.L.C.

KLC

KinderCare Learning Companies, Inc.

AI score

Similar quality profile · 2 shared holders

CastleKnight Management LP Blackstone Inc.

Chemours Co

AI score

Similar quality profile · 6 shared holders

T. Rowe Price Investment Management, Inc.Penn Capital Management Company, LLC Blackstone Inc.

BKD

Brookdale Senior Living Inc.

AI score

Similar quality profile · 7 shared holders

Quinn Opportunity Partners LLC DARK FOREST CAPITAL MANAGEMENT LP Counterpoint Mutual Funds LLC

OLN

OLIN Corp

AI score

Similar quality profile · 5 shared holders

CastleKnight Management LP DARK FOREST CAPITAL MANAGEMENT LP Blackstone Inc.

SEM

SELECT MEDICAL HOLDINGS CORP

AI score

Similar quality profile · 4 shared holders

Penn Capital Management Company, LLC MIRABELLA FINANCIAL SERVICES LLP Blackstone Inc.

INNV

InnovAge Holding Corp.

AI score

Similar quality profile · 3 shared holders

T. Rowe Price Investment Management, Inc.ZACKS INVESTMENT MANAGEMENT MIRABELLA FINANCIAL SERVICES LLP

MOH

MOLINA HEALTHCARE, INC.

AI score

Similar quality profile · 2 shared holders

T. Rowe Price Investment Management, Inc.LEVEL FOUR ADVISORY SERVICES, LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put SGRY on your watchlist

Track score changes the day Surgery Partners, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is SGRY a good stock to buy?

13F Pro's AI-powered analysis of Surgery Partners, Inc. (SGRY) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SGRY are available on the SGRY stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. SGRY is classified as a small company.

Which hedge funds own SGRY?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SGRY. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Surgery Partners, Inc.'s investment landscape.